Good morning, everyone, and welcome to the Trulieve Cannabis Corporation First Quarter 2025 Financial Results Conference Call. My name is Debbie, and I will be your conference operator for today. As a ...

Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trialsMultiple near-term catalysts anticipated with the potenti ...